| http://www.w3.org/ns/prov#value | - Also provided in the present invention is a method of treating a patient suffering from an ischemic condition comprising administering a therapeutic amount of a pharmaceutical composition comprising a 6b-modified VEGF protein, preferably VEGF-A138, VEGF-A162, or VEGF-A182, in a suitable carrier.
|
